Objectives: Ovarian cancer is often diagnosed at an advanced stage, and consequently high levels of distress are often experienced. It is necessary to understand the factors associated with psychological distress in order to guide interventions to target those factors. The purpose of this systematic review was therefore, to identify correlates of psychological distress in ovarian cancer.
Ovarian cancer is usually diagnosed at an advanced stage and the overall 5-year survival rate is approximately 40% [1] . Treatment usually involves radical surgery and chemotherapy, which can have a significant impact on quality of life, and risk of recurrence is high [1] . Not surprisingly, a number of studies have found elevated levels of anxiety and depression in patients with ovarian cancer [2] [3] [4] . However, one longitudinal study [5] found that 23% of ovarian cancer patients experienced little or no distress. Thus, the psychological sequelae of ovarian cancer is quite heterogeneous. Identifying systematic and reliable research-based risk factors of psychological distress/reduced quality of life could help to guide psychological support and/ or interventions to those who require them the most. This is a significant issue. A study of 143 women with ovarian cancer found that although 55% of participants had experienced some depressive symptoms, very few had been offered counselling [3] . Further, a search of the literature from 1980 -2005 revealed only five psychological intervention studies for patients with gynaecologic cancers [6] [7] [8] [9] [10] . To further this research, it is necessary to identify correlates of psychological distress. This will allow us to improve screening for interventions, guide their therapeutic contents and improve their efficacy. In order to identify such correlates, it is necessary to review the literature carefully, assessing articles for study quality. The latter could vary widely and significantly affect the inferences that can be drawn.
A review on quality of life in ovarian cancer [11] noted several methodological limitations. First, the absence of a clear-cut definition of quality of life led to uncertainties in theoretical and operational concepts. Second, very few studies controlled for disease stage and other prognostic factors. Third, many studies modified valid versions of psychometric instruments. Fourth, many studies used small samples with possible insufficient statistical power. Some studies included patients with a variety of cancers, without presenting results for ovarian cancer patients separately, making inferences about ovarian cancer nearly impossible. Since many different measures were used, it was not possible to do a metaanalysis. Overall, only limited conclusions could be drawn. Although many of these issues have been addressed in subsequent studies, others, such as the ratio of variables to participants, use of non-standardized questionnaires, and failure to report results by type of cancer are still prevalent.
However, during the past decade there has been a substantial increase in research assessing levels of psychological distress and factors affecting psychological adjustment in ovarian cancer. Although Pearman [12] carried out a review on quality of life and psychosocial adjustment in gynaecologic cancer survivors, several issues limit the conclusions that can be drawn by this review. First, no specific period for the literature search was provided. Second, the only database searched was Medline. Third, gynaecologic cancer patients were not differentiated, although factors that may affect psychological adjustment can differ considerably depending on diagnosis. For example, ovarian cancer generally has a worse prognosis than cervical and endometrial cancers, since it is more likely to be diagnosed at a later stage. Furthermore, in recent years new articles on distress in ovarian cancer have been published. Fourth, the strength of evidence could not be assessed, as studies were not quality assessed.
The purpose of this review was to assess correlates of psychological distress (conceptualized as levels of anxiety and depressive symptoms) in ovarian cancer. This review covered the period from January 1994 (to include any articles missed by the previous review on quality of life in ovarian cancer) to May 2007. The studies were quality assessed, and divided into good, average and poor quality, in order to assess the strength of evidence.
Method
Four methods were used to locate relevant studies: a keyword search, a backward search, a manual search of relevant journals, and a manual conference program search.
Using the keyword search method, we searched the databases Medline, PsycInfo and Embase for articles published in the English language covering the period from January 1994 to May 2007, with the provision that any articles published in 1994 and included in the previous review [11] were not included. The search included the following terms: ovarian cancer NOT genetic (because the review was concerned with women who already had ovarian cancer), ovarian carcinoma, gynaecologic cancer, gynecologic cancer, psych$, depression, major depression, anxiety, anxiety disorders, distress, and stress. After each term had been entered into the keyword function, the cancer-related terms were combined using the OR function, and so were the psychological terms. A further search was then conducted, whereby the results of the previous searches were combined using the AND function. This generated 798 hits. Overall, the keyword search yielded 49 articles.
Following the keyword search, we carried out a backward search, in which we located papers by examining the reference lists of all papers obtained from the first step (as well as a recent non-systematic literature review; Pearman, 2003) . This did not identify any further articles.
We then carried out a manual search of the journals Gynecologic Oncology (from which we had identified a number of articles) and Psycho-Oncology for the period January 1994 -May 2007. This did not identify further articles.
Following this, we contacted the authors of unpublished dissertations, to enquire whether they had written any relevant articles based on their dissertation. This method identified a further two manuscripts.
We also examined the abstracts of the 2006 World Congress of Psycho-Oncology. This identified a further 3 studies. Overall, 49 published studies and 5 unpublished studies were identified.
Following this, we e-mailed the authors of the unpublished studies to request manuscripts.
One author was not contactable at the email address provided. A further two authors did not respond with sufficient information to enable inclusion of their studies in this review. Therefore, only 2 unpublished studies were obtained.
Inclusion and exclusion criteria
To be included, studies had to meet the following criteria: 1) Either include ovarian cancer patients only, or to present the results for ovarian cancer patients separately. Twenty-one studies were excluded according to this criterion, either because they were concerned only with patients with cervical and endometrial cancer (3 studies), or because ovarian cancer results were not presented separately (18 studies).
2) Be a quantitative study with standardized or validated measures of psychological distress. Nine studies with qualitative methods were excluded.
3) Present new data not already reported in an earlier source. Three articles were excluded according to this criterion.
Extracted information
The following information was extracted from each study: report information (authors, year of study, source of study), ovarian cancer sample size, age of participants, disease stage at diagnosis, time since diagnosis, measures used (including whether they were standardized), design and major findings.
Ratings of study quality A methodological quality assessment list was used to assess the studies. This was devised based on reviewing existing quality assessment lists, [13, 14] extracting those criteria that were considered relevant, and devising further ones based on consultation, to cover all sections of the articles. Since quality assessment was generic, the criteria could be applied to a variety of different types of study design. These criteria are summarized and elaborated on in Table 1 . To reduce subjectivity in ratings, most criteria (10/12) could be assessed objectively with little interpretation. Each criterion was assessed out of 3 points (poor, medium and good). Appendix 1 provides a full account of the quality assessment tool.
Overall assessment
The studies are summarized in Table 2 together with their findings. They were assessed out of 36 points. Studies that scored 30 points or above (> 80%) were classified as good, those that scored 26-29 points were classified as average, and those scoring 25 points or lower were classified as poor.
When collating the findings, the strength of evidence for a relationship between demographic and other factors and psychological adjustment was assessed by defining three levels of evidence. Levels of evidence were based on those set out by Ariens et al. [13] , and related to both quantity and quality, and are as follows: 1. Strong evidence: Consistent findings across two or more good studies; 2. Some evidence: Consistent findings across two or more studies, where at least 1 must be average; 3. Inconclusive evidence: Consistent findings in multiple poor studies, inconsistent findings, or only one study is available, irrespective of quality.
Results
Eighteen studies were identified in this systematic review. The majority were carried out in the USA (11 studies). Other studies were carried out in Australia (3 studies), Canada (1 study), Hong Kong (2 studies), and the UK (1 study). Thirteen of the studies dealt with ovarian cancer patients only (2 of those studies focused on survivors), and 5 dealt with women with a variety of gynaecologic cancers including ovarian cancer, for which the pertinent results could be interpreted.
The quality assessment highlighted a number of limitations with the studies.
First, psychological studies were less likely to report biomedical variables, such as type of treatment, and medical studies were less likely to report other demographic variables, such as socioeconomic status (SES), and marital status. Second, some studies that compared the prevalence of anxiety and depression in ovarian cancer patients to the general population did not have a control group. Third, there were a few issues with the statistical tests -dividing data into quartiles to address the issue of skew, rather than transforming variables (1 study) and doing Pearson correlations only, rather than regression (2 studies). Fourth, means and standard deviations were not always reported. Fifth, many studies had rather small samples -eight failed to meet the criterion of 10 participants per independent variable required for 3 points.
Finally, some of the studies used non-standardized assessment tools (that had not been validated and published) to assess secondary outcomes. Table 1 provides the major limitations of each study.
Overall, twelve of the studies were rated as methodologically good, five were rated average, and one was rated poor. Levels of depression in ovarian cancer groups tended to be higher than in community samples, with percentages of those scoring above the clinical cut-off ranging from 21-25% in the good studies, to 33% in the poor study [5] (though, interestingly, this study found that 23% of individuals experienced little or no distress). Notably, the prevalence of depression decreased after the three month period following completion of treatment [21] , although it does not appear to differ across the first 6 weeks post-diagnosis [27] . However, it is important to note that studies involving patients who were at varying stages of their cancer journey found approximately that approximately 25% of participants scored above the clinical cut-off, suggesting that depressive symptoms may remain a significant problem for some patients. Studies that looked at ovarian cancer survivors found that 6% of ovarian cancer survivors, defined as those who had been 2 years or more without evidence of active disease, scored above the clinical cut-off for depression [29] , which is comparable to the general population and survivors scored higher on the Mental Health Inventory than population norms, indicating better mental health than the general population [28] . Overall, levels of anxiety tended to be higher than levels of depressive symptoms [3] . Hipkins et al. [21] reported that the prevalence of clinical levels of anxiety was 47% 3 months after finishing treatment, and that anxiety increased from completion of treatment to 3 month follow-up.
Correlates of levels of anxiety and depressive symptoms are reported in Table 3 .
One factor constantly associated with increased levels of distress in ovarian cancer patients included younger age, where evidence was found in five good studies [3, 4, 15, 16, 26] and one average study [21] . In contrast, 1 average study [28] found no relationship between age and depressive symptoms in ovarian cancer survivors, and one good study [25] found lower levels of distress in women under 45 years old. The weight of the evidence therefore strongly suggests that younger patients experience more anxiety/depression.
Being diagnosed with advanced stage disease was associated with increased levels of psychological distress in three good studies [3, 16, 25] and one poor study [5] Based on these results, there is strong evidence that having advanced stage disease at diagnosis is associated with higher levels of psychological distress. Shorter time since diagnosis was associated with increased levels of distress in three good studies [3, 17, 22] , although it is important to note that this was not assessed in a large number of studies, since participants were often recruited when they were newly diagnosed.
Worse performance status was associated with increased levels of psychological distress in one good study [15] and one poor study [5] , although one average study [21] , found no relationship between Karnofsky performance status and levels of depression/anxiety. This suggests inconclusive evidence for a relationship between Karnofsky performance status and levels of psychological distress.
Increased levels of physical impairment was related to increased levels of psychological distress in two good studies [4, 22] and one poor study [5] . Related to this, 1 average study on ovarian cancer survivors [29] found that increased levels of self-reported neurotoxicity was associated with increased levels of depression. From these findings, it was concluded that there is strong evidence for a relationship between increased levels of physical symptoms and increased levels of psychological distress. Phase of treatment (active/ follow-up) was not associated with levels of depression/anxiety, in the one good study that addressed this issue [16] . Also no differences in psychological distress were found between those with newly diagnosed and recurrent cancer in one average study [20] , suggesting that both cancer phases are psychologically equally difficult.
Regarding cancer site, three studies assessed several different types of gynaecologic cancers. Two good studies [16, 17] and one average study [27] found no differences between patients with ovarian cancer and those with other types of gynaecologic cancers. However, one good study [25] found that women with ovarian cancer experienced lower levels of depressive symptoms than those with cervical and endometrial cancer. This study included very few participants with advanced stage disease, which may account for this difference. These results do not suggest any clear relation between cancer site and levels of psychological distress.
Poor perceived social support was associated with increased levels of anxiety and depression in one good study [4] and two average studies [21, 27] . This was assessed in different ways across the studies i.e. perceived social support [27] , perceived emotional support [21] , and perceived unsupportive family/friend behaviours [4] , which adds to the robustness of the evidence. These findings suggest moderate evidence for a relationship between perceived social support and levels of psychological distress. Also, depression at time of diagnosis was a significant predictor of depressive symptoms 3 months later, and levels of anxiety and intrusive thoughts at time of diagnosis were significant predictors of levels of anxiety 3 months later in one average study [21] .
Increased levels of distress were associated with worse quality of life in two good studies [22, 25] . However, these results should be viewed with caution, because although Molassiotis et al. [25] found that depression accounted for 45% of the variance in quality of life, the scale used contained mood items.
Finally, some interesting issues were assessed in single studies. The relationship between levels of distress and immune factors was assessed in three good studies [18, 23, 24] . Costanzo et al., [18] found that a history of depression and increased depressed mood were associated with higher levels of interleukin-6 in ascitic fluid.
Lutgendorf et al. [23] , found that higher levels of helplessness were associated with higher levels of vascular endothelial growth factor, a pro-angiogenic factor which is positively correlated with anxiety and depression at baseline, but no prospective relations were found. Boscaglia et al. [16] , in a good study, found that increased levels of negative religious coping (i.e., confusion and dissatisfaction with God, redefining the illness as a punishment) were associated with higher levels of anxiety and depression. The results from these studies point at possible complex relations between information-seeking, coping and distress in ovarian cancer.
Discussion
In order to identify correlates of psychological distress in ovarian cancer, a systematic review of the literature was carried out. The results showed strong evidence for a relationship between younger age, being diagnosed with more advanced disease, more physical symptoms and shorter time since diagnosis with increased levels of anxiety and depression; some evidence for a relationship between low perceived social support and worse performance status and increased levels of anxiety/depression was also found. There was inconclusive evidence for a relationship between being on active chemotherapy, having a recurrence and having ovarian cancer (compared to other gynaecologic cancers) and levels of anxiety/depression.
While the evidence for a relationship between quality of life and distress could be viewed as strong based on our criteria, the issue of item overlap (quality of life instruments often include measures of mood) spuriously inflated this relationship.
Overall, a consistent relationship was found between younger age and increased levels of anxiety/ depression. Similar findings have been reported in other cancers i.e., Strong et al. [30] . Individuals diagnosed at a younger age have several issues to contend with, including the impact of their diagnosis on those around them (e.g., spouses, children), issues about childbearing, multiple unfulfilled goals, and the possibility of an early death. Although younger women are more likely to be married (than widowed), and possibly have a wider social network, the disease is more likely to impact on their everyday life. The evidence presented here suggests that younger women should be carefully assessed for symptoms of anxiety and depression.
Physical symptoms and impairment were also associated with increased levels of anxiety and depression, possibly because they are viewed as indicators of disease progression. In addition, some treatment-induced physical symptoms (e.g., nausea) may either induce or be associated with altered mood state as part of the "sickness response" [31] . Similarly, lower performance status was associated with increased levels of anxiety/ depression. This evidence suggests that individuals with limited ability to perform daily activities may benefit from psychological interventions, and that psychological interventions should be tailored to accommodate their limitations (i.e., by phone for people who are unable to travel). Alternatively, depression or anxiety may lead to poorer performance status because depressed patients have reduced motivation [32] leading to reductions in energy expenditure required for daily activities. It is also plausible that relations between self-reported physical symptoms and distress may reflect the underlying personality trait of neuroticism [33] , manifested by corresponding scores on both outcomes. Objective measures of physical health or statistically controlling for neuroticism may be required to test the true relation between impairment and distress.
More advanced disease was associated with increased levels of distress in newly diagnosed patients. Advanced stage disease is associated with poorer survival and more symptoms, and patients are obviously aware of these threats. This evidence suggests that individuals diagnosed with advanced disease should be carefully assessed for anxiety and depression.
As in other cancers [34] , levels of anxiety/ depression tended to decrease as time since diagnosis increased. A cancer diagnosis is a traumatic event, and coming to terms with it requires a significant shift in perspective, which could explain these findings. This may reflect an adaptation process.
As expected, poorer quality of life was significantly associated with increased levels of anxiety/ depression. Experiencing more physical symptoms and reduced ability to engage in leisure activities/ work is likely to decrease self-esteem, possibly leading to greater distress. Future studies need to test whether self-esteem mediates such a relation. This evidence suggests that interventions targeting quality of life are a high priority area for future research, and should be made widely available, particularly given the relations between quality of life and distress/ survival [35, 36] .
However, as mentioned above, these relations may partly stem from item overlap and need to be tested by removing distress items from quality of life instruments. As expected, given previous studies on other types of cancer, i.e., Helgeson & Cohen, [37] poor perceived social support was associated with increased levels of anxiety and depression. This may result from patients not receiving sufficient emotional or instrumental support from close friends/ relatives. Alternatively, high patient distress may lead to reduced social support due to significant others not having the skills to manage such distress.
The evidence assessed here suggests no differences in levels of anxiety and depression between patients with ovarian cancer and those with other gynaecologic cancers. Similar findings were observed in two excluded studies [38, 39] . Ovarian cancer has a worse prognosis as it is more likely to be diagnosed at an advanced stage, and consequently requires more aggressive treatment, both of which are distressing.
However, provided disease stage was controlled for in these studies, this lack of difference is expected since cancer can be life threatening and all gynaecologic cancers may affect sexual relations and intimacy. Thus, other factors related to the disease mentioned above, rather than the mere diagnosis of ovarian cancer, should be considered when assessing anxiety and depression [5] .
Being on active chemotherapy treatment was not associated with increased risk of anxiety and depression. This was surprising since chemotherapy can cause a number of unpleasant side effects, often greatly reducing life satisfaction and inducing the sickness response. A number of the studies here included only newly diagnosed individuals. However, patients undergoing chemotherapy are aware that their condition is being treated, which may reflect an important source of medical support.
Upon completion of treatment, some patients experience anxiety that their progress is not being monitored, and that they will be unaware of a recurrence (particularly since ovarian cancer can be asymptomatic). Similar "separation anxiety" is found in patients leaving the intensive coronary care unit for less intensive monitoring and care in other parts of hospitals [40] . Also surprisingly, having a recurrence was not associated with increased levels of anxiety and depression. In these studies, individuals who had a recurrence were compared with newly diagnosed patients.
Comparing patients who had a recurrence with disease-free individuals at a similar time since diagnosis may yield different results. Alternatively, this result could be explained in the following way: by the time of recurrence, some individuals have been living with their illness for several years, and may have come to terms with their diagnosis and treatment -news of a recurrence may be less surprising than the initial diagnosis. This issue requires further research.
A few well-designed studies found that various indices of distress were correlated with biomarkers of prognostic factors in ovarian cancer (e.g., VEGF, IL-6). Since distress may lead to altered immune function, interventions to reduce distress need to be made a priority. These studies are important since they point at potential mediators linking psychological factors with prognosis in ovarian cancer e.g. [41] . However, this needs to be tested in longitudinal studies and randomized controlled trials, which would provide a better understanding of the direction of the relation between immune factors and psychological distress.
Regarding methodology/ reporting, several issues need to be addressed in future studies. First, information should be collected on whether the individual is living alone or with a partner, socioeconomic status, type of treatment received and whether the patient has had a recurrence. Second, more prospective studies and randomizedcontrolled trials are needed, the latter enabling causal inferences and having potential clinical value. In addition, longitudinal studies should test trajectories of change in distress following diagnosis and treatment. Third, more attention should be given to sample size. Fourth, questionnaires should be validated prior to usage if possible.
Fifth, importantly, studies should use models to structure their research questions -to date, most studies have not been based on theory regarding adjustment to illness [42, 43] . Finally, limitations and possible future directions for research should be provided. Although some of these conclusions echo those of Montazeri et al. [11] , which would suggest lack of progress in recent years, the studies published in the current decade were rated 'average' or better, in contrast with the study published in the 1990s. It is also encouraging to see that the volume of published research on ovarian cancer has been increasing in recent years -over half the studies included in this review were published after 2003. In addition, the studies revealing relationships between distress and disease biomarkers indicate promising avenues and call for testing whether treating distress could alter such biomarkers and improve prognosis in ovarian cancer. Also, some studies point to a number of modifiable factors affecting levels of distress, such as levels of knowledge and coping strategies, which were not assessed in the ovarian cancer literature before the late 1990s. Given recent reviews on psychological interventions and prognosis in cancer [44] , future studies need to design alternative interventions for modifying psychosocial factors.
This systematic review had a few limitations. A number of authors were reluctant to provide details of unpublished studies, which consequently could not be included. Some correlates of distress (e.g., immune factors, coping) were tested in too few studies to enable firm conclusions.
Overall, this review has provided a first step towards identifying factors that may impact on psychological distress in ovarian cancer, a disease that has often been neglected in psycho-oncology research until recently. This is also the first review to quality assess studies, and therefore provides a more stringent test of the evidence than previous reviews on ovarian cancer. The evidence here can be used as a preliminary guide when deciding which patients to assess for anxiety and depression and whom to target when designing psychological interventions.
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